The Times of India on MSN2 天
Aurobindo Pharma Q2 net profit rises 9%
Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in con ...
The following is a summary of “Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United ...
While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.
Faropenem is an oral carbapenem, beta-lactam antibiotic which is used for the treatment of upper and lower respiratory tract infections, urinary tract infections, skin infections, and ...
particular care must be administered to the pregnant patient (clinical practice for those with mild to moderate pneumonia can reasonably include beta-lactam antibiotics -- ie, amoxicillin ...
The manuscript explores how bacterial evolution in the presence of lytic phages modulates b-lactams resistance and virulence properties in methicillin-resistant Staphylococcus aureus (MRSA). The work ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. The act of "unlevering" beta involves ...
Venatorx meanwhile is developing a pipeline of novel combinations of beta-lactam antimicrobials and beta-lactamase inhibitors – drugs used alongside the antibiotics to prevent resistance – for ...
Winner to be Presented at BIO-Europe 2024 in Stockholm, SwedenROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ ...
Methicillin-resistant Staphylococcus aureus, which causes 120,000 deaths a year, adopts an alternative mode of cell division ...
Founded on the principles of innovation and patient need, Theriva™ Biologics is a diversified clinical-stage company focused on developing groundbreaking therapeutics to combat cancer and related ...